Diane Eannotti, RN

Bridgeport HospitalBridgeport, Connecticut - 06610 (203-384-4849) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2006

A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
December 2006 - May 2010
Breast Neoplasms
Trastuzumab
Rapamycin



